Cargando…

Metabolism of ifosfamide during a 3 day infusion.

Urinary drug metabolites were measured in 21 patients receiving ifosfamide by continuous infusion over 3 days. Mean values for the proportion of drug excreted as parent compound, 2-dechloroethylifosfamide (2-DC), 3-dechloroethylifosfamide (3-DC), carboxyifosfamide (CX) and ifosforamide mustard (IPM)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartley, J. M., Hansen, L., Harland, S. J., Nicholson, P. W., Pasini, F., Souhami, R. L.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968912/
https://www.ncbi.nlm.nih.gov/pubmed/8180026
_version_ 1782134843977498624
author Hartley, J. M.
Hansen, L.
Harland, S. J.
Nicholson, P. W.
Pasini, F.
Souhami, R. L.
author_facet Hartley, J. M.
Hansen, L.
Harland, S. J.
Nicholson, P. W.
Pasini, F.
Souhami, R. L.
author_sort Hartley, J. M.
collection PubMed
description Urinary drug metabolites were measured in 21 patients receiving ifosfamide by continuous infusion over 3 days. Mean values for the proportion of drug excreted as parent compound, 2-dechloroethylifosfamide (2-DC), 3-dechloroethylifosfamide (3-DC), carboxyifosfamide (CX) and ifosforamide mustard (IPM) were 19, 6, 10, 7 and 8% of dose respectively. The proportion of urinary drug products in the form of ifosfamide fell considerably over the course of the 3 days. This was mirrored by an increase in the proportion of 2-DC, 3-DC and CX. The proportion in the form of IPM, however, remained unchanged. With successive cycles the amount of 2-DC and IPM increased by about 10% per course. A very wide variation in the amount of each metabolite was reproducibly seen between patients, but no evidence for a genetic polymorphism was found. Urinary dechloroethyl metabolites correlated positively with each other and negatively with CX. Although autoinduction increases 'activation' of ifosfamide when given over 3 days, our evidence suggests that competing metabolic pathways prevent an increase in the amount of active metabolite formed.
format Text
id pubmed-1968912
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19689122009-09-10 Metabolism of ifosfamide during a 3 day infusion. Hartley, J. M. Hansen, L. Harland, S. J. Nicholson, P. W. Pasini, F. Souhami, R. L. Br J Cancer Research Article Urinary drug metabolites were measured in 21 patients receiving ifosfamide by continuous infusion over 3 days. Mean values for the proportion of drug excreted as parent compound, 2-dechloroethylifosfamide (2-DC), 3-dechloroethylifosfamide (3-DC), carboxyifosfamide (CX) and ifosforamide mustard (IPM) were 19, 6, 10, 7 and 8% of dose respectively. The proportion of urinary drug products in the form of ifosfamide fell considerably over the course of the 3 days. This was mirrored by an increase in the proportion of 2-DC, 3-DC and CX. The proportion in the form of IPM, however, remained unchanged. With successive cycles the amount of 2-DC and IPM increased by about 10% per course. A very wide variation in the amount of each metabolite was reproducibly seen between patients, but no evidence for a genetic polymorphism was found. Urinary dechloroethyl metabolites correlated positively with each other and negatively with CX. Although autoinduction increases 'activation' of ifosfamide when given over 3 days, our evidence suggests that competing metabolic pathways prevent an increase in the amount of active metabolite formed. Nature Publishing Group 1994-05 /pmc/articles/PMC1968912/ /pubmed/8180026 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Hartley, J. M.
Hansen, L.
Harland, S. J.
Nicholson, P. W.
Pasini, F.
Souhami, R. L.
Metabolism of ifosfamide during a 3 day infusion.
title Metabolism of ifosfamide during a 3 day infusion.
title_full Metabolism of ifosfamide during a 3 day infusion.
title_fullStr Metabolism of ifosfamide during a 3 day infusion.
title_full_unstemmed Metabolism of ifosfamide during a 3 day infusion.
title_short Metabolism of ifosfamide during a 3 day infusion.
title_sort metabolism of ifosfamide during a 3 day infusion.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968912/
https://www.ncbi.nlm.nih.gov/pubmed/8180026
work_keys_str_mv AT hartleyjm metabolismofifosfamideduringa3dayinfusion
AT hansenl metabolismofifosfamideduringa3dayinfusion
AT harlandsj metabolismofifosfamideduringa3dayinfusion
AT nicholsonpw metabolismofifosfamideduringa3dayinfusion
AT pasinif metabolismofifosfamideduringa3dayinfusion
AT souhamirl metabolismofifosfamideduringa3dayinfusion